Beta
338916

Comparison between Agonist & Antagonist Risks and Outcome

Article

Last updated: 29 Dec 2024

Subjects

-

Tags

Ovarian stimulation

Abstract

Background: An essential part of ovarian stimulation in Invitro Fertilization /Intra-Cytoplasmic Sperm Injection (IVF/ICSI) involves co-medication to prevent premature luteinization. Controlled ovarian hyperstimulation (COH) is a fundamental step. Most published reviews have insufficiently accounted for various patient populations, who are likely to be of relevance since they strongly differ about ovarian responsiveness, particularly in relation to the long agonist and antagonist protocols. Both protocols are effective in blocking premature LH surges. The main two approaches for this are pituitary desensitization with prolonged daily administration of a gonadotrophin releasing hormone (GnRH) agonist or an instant blockade of the pituitary luteinizing hormone (LH) secretion with a GnRH antagonist.
Objectives: The study aimed to compare risk and outcome of agonist and antagonist stimulation protocols.
Materials and methods: This study was carried out in ART Unit of RIYADA fertility center for year 2020-2021 include 320 patients. Patients were subdivided into two groups: Long protocol group (n = 241) was stimulated by GnRH agonist long protocol, and Antagonist Group (n = 79) was stimulated by antagonist protocol.
Results: The multiple logistic regression analysis for different risk factors of pregnancy, was significant, and the significant items were protocol used (long protocol), young age, high number of oocytes, the three items gave a high pregnancy rate if combined.
Conclusion:
The study concluded that the long protocol shows a high pregnancy rate in certain patient groups who fulfill the following criteria; age less than 37 years; Number of oocytes less than 15.

DOI

10.21608/jrme.2024.265325.1008

Keywords

GnRH, PCO, COH, LH

Authors

First Name

Ahmed

Last Name

Mashaly

MiddleName

-

Affiliation

Obstetrics and Gynecology Department, Damanhour National Medical Institute, Egypt. , RYADA Fertility Center, Damanhour, Egypt., Egyptian Foundation of Reproductive Medicine and Embryology (EFRE), Egypt.

Email

ahmedmashaly55@yahoo.com

City

-

Orcid

-

First Name

Ashraf

Last Name

Abo Ali

MiddleName

-

Affiliation

Egyptian Foundation of Reproductive Medicine and Embryology (EFRE), Egypt., Madina ICSI Fertility Center, Madina women's hospital, Alexandria, Egypt.

Email

aboalimadinahospital@gmail.com

City

-

Orcid

-

First Name

Yasser

Last Name

ElKassar

MiddleName

-

Affiliation

Egyptian Foundation of Reproductive Medicine and Embryology (EFRE), Egypt., Obstetrics and Gynecology Department, Faculty of Medicine, Alexandria University, Egypt.

Email

yasser_elkassar@hotmail.com

City

-

Orcid

-

Volume

1

Article Issue

2

Related Issue

49552

Issue Date

2024-07-01

Receive Date

2024-01-24

Publish Date

2024-07-01

Page Start

118

Page End

133

Online ISSN

3009-7282

Link

https://jrme.journals.ekb.eg/article_338916.html

Detail API

https://jrme.journals.ekb.eg/service?article_code=338916

Order

7

Type

Original Article

Type Code

2,940

Publication Type

Journal

Publication Title

Journal of Reproductive Medicine and Embryology

Publication Link

https://jrme.journals.ekb.eg/

MainTitle

Comparison between Agonist & Antagonist Risks and Outcome

Details

Type

Article

Created At

20 Dec 2024